基质金属蛋白酶及其抑制剂与消化道肿瘤的侵袭和转移
Relationship between matrix metalloproteinase and its inhibitor to the invation and metustasis of gastro-enteric tumor
出处
《中国当代儿科杂志》
CAS
CSCD
2001年第6期732-734,共3页
Chinese Journal of Contemporary Pediatrics
参考文献21
-
1Sun Y, Wenger L. P53 down regulates human matrix metalloproteinase-1 gene expression [J]. J Biol Chem, 1999, 274(17):11535-11540.
-
2Vincenti MP, White LA, Schroen Dj, et al. Regulating expression of the gene for matrix metalloproteinase-1(collagenase):mechanisms that control enzyme activity, transcription, and mRNA stability [J]. Crit Rev Eukaryot Gene Expr. Crit Rev Eukaryot Gene Expr, 1996, 6(4): 391-411.
-
3Strongin AY, Collier I, Bannikov G, et al. Mechanism of cell surface activation of 72-kDa type Ⅳ collagenase. Isolation of the activated form of the membrane metalloprotease [ J ]. J Biol Chem, 1995, 270(10): 5331-5338.
-
4Kjmlman M, Enberg U, Hoog A, et al. Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA expressed in adenocortical cancer but not in adenomas [J]. World J Surg, 1999, 23(3): 237-242.
-
5Martinella CC, Nawrocki B, Gilles Cet al. Matrix metalloproteinases in bronchpulmonary carcinoma [J]. Histol Histopathol,1999, 14(3): 839-843.
-
6KuglerA. Matrix metalloproteinases and their inhibitors[J]. Anticancer Res, 1999, 19(2C): 1589-1592.
-
7Ara T, Kusafuka T, Inoue M, et al. Determination of imbalance between MMP-2 and TIMP-2 in human neuroblastoma by reverse-transcription polymerase chain reaction and its correlation with tumor progression [J]. J Pediatr Surg, 2000, 35(3): 432-437.
-
8Sier CF, Kubben FJ, Ganesh S, et al. Tissue levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 are related to the overall survival of patients with gastric carcinoma [J]. Br J Cancer, 1996, 74(3):413-417.
-
9Miyazaki k, Koshikawa N, Hasegawa S, et al. Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastic agents [J]. Cancer Chemother Pharmacol, 1999, 43(SUPPL): s52-55.
-
10Terada T, Okada Y, Nakanuma Y, et al. Expression of immunoreactive matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in human normal livers and primary liver tumors [J]. Hepatology, 1996, 23(6): 1341-1344.
-
1郭华,邓志锋,刘泉开.基质金属蛋白酶与脑动脉瘤[J].实用临床医学（江西）,2002,16(2):115-117. 被引量：1
-
2林峰.基质金属蛋白酶及其抑制剂与大肠癌肝转移的研究进展[J].肿瘤学杂志,2002,8(3):174-176. 被引量：4
-
3王剑火,施作霖,陈梓甫.基质金属蛋白酶及其抑制剂与几种常见的泌尿系肿瘤[J].临床与实验病理学杂志,2000,16(3):247-248. 被引量：3
-
4王岩,刘晓霞,侯正文,柳春晖,马秀萍,陈丽萍,贾支红,方虹.基质金属蛋白酶及其抑制剂在乳腺癌转移、浸润中的作用[J].临床与实验病理学杂志,2002,18(3):273-275. 被引量：12
-
5吴登龙.基质金属蛋白酶及其抑制剂与泌尿系肿瘤的浸润与转移[J].国外医学（泌尿系统分册）,1998,18(1):30-33. 被引量：10
-
6许璟,刘伟国.基质金属蛋白酶及其抑制剂与脑肿瘤侵袭转移的关系[J].浙江创伤外科,2002,7(2):138-140.
-
7刘嵘,丁华野.基质金属蛋白酶及其抑制剂与乳腺癌的浸润与转移[J].诊断病理学杂志,2000,7(4):298-300. 被引量：3
-
8刘辉,吕丽琼,莫小勤,成名,杨杰.MMP-2、MMP-7、MMP-9、TIMP-1及TIMP-2在乳腺癌组织中的表达及意义[J].现代生物医学进展,2015,15(16):3046-3048. 被引量：17
-
9高峰,刘思源,胡彤宇,王晓梅,赵玉峰.基质金属蛋白酶及其抑制剂在软骨肉瘤中的表达及临床意义[J].中华实验外科杂志,2011,28(4):614-614. 被引量：1
-
10马冬.术前血TIMP-1水平与结直肠癌预后密切相关[J].循证医学,2010,10(4):197-197.
